Indications and uses
• For the treatment of acne
• For the treatment of acne
• In the shower, lather with water. • Massage all over wet skin, paying special attention to areas with acne. • Rinse thoroughly.
Salicylic Acid 2%
Acne treatment
• For the treatment of acne
For external use only.
• Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor. • Do not get into eyes. tt excessive skin irritation develops or increases, discontinue use and consult a doctor. • If product is swallowed, get medical help or contact a Poison Control Center right away.
• In the shower, lather with water. • Massage all over wet skin, paying special attention to areas with acne. • Rinse thoroughly.
Water, Decyl Glucoside, Lauryl Glucoside, Sodium Cocoyl isethionate, Cocamidopropyl Betaine, PEG-150 Distearate, Sodium Cocoamphoacetate, Panthenol, Hamamelis Virginiana (Witch Hazel) Leaf Extract, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Salix Alba (Willow) Bark Extract, pilobium Fleischeri Flower/Leaf/Stem Extract, Chamomilla Recutita (Matricaria) Flower Extract, Lavandula Angustifolia (Lavender) Oil, Mentha Piperita (Peppermint) Leaf Oil, Glycerin, Coconut Acid, Sodium Chloride, Sodium Cocoyl Glutamate, Sodium Lauryl Glucose Carboxylate, Parfum (Fragrance), Chlorphenesin, Disodium EDTA, Phenoxyelhanol, Citric Acid.
Protect this product from excessive heat and direct sun.
1-800-253-1983
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 83010-011 | 83010-011-00 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 36b89e2e-4b20-67df-e063-6294a90ae26d | e4ff846b-2c25-40cb-a669-50dd9338d3c9 | 2025-06-04 | Warnings | 36b89e2e-4b20-67df-e063-6294a90ae26d e4ff846b-2c25-40cb-a669-50dd9338d3c9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.